We would love to hear your thoughts about our site and services, please take our survey here.
Darth, l agree, been here for three years and happy to hold but people clutching at straws on news every month - it will hopefully arrive in due course but think there is more for THX to do for 201 financing and the rest will arrive in time. Patience - Rome wasn’t built in a day as they say!
LOL, reckon about 500,000 sellers today to 150,000 buyers, but don’t take it to heart Ice! The price may slip down further (l reckon support at circa 13p without news, but l am no tea leaf specialist) as we await news but if you are a LTH then don’t worry about the daily fluctuations - it’s a market after all!
I reckon we shouldn’t get excited and wait for end of year for an update.
Hi mate, l think we shoudn’t read in to it too much and wait for an outcome.
Everyone waited with baited breath now (like me) on THX but the last Cenkos report said they evaluated the valuation proposition of THX coming in by 2023 hopefully in theory, so maybe a red herring that we are expecting something shortly?
Lets wait and been here for over 3 years now so happy to wait!
GLA
Go, go, go VAL!
Don’t forget the £2.2mn from THX when it hopefully arrives :)
Jeez guys, calm down - your all like dogs on heat!
Northern, the answer is wtfdik!
But look at 2.5 years!
Toxic loans gone
New BOD with corporate and scientific experience
Massive cost cutting from 300k pm to £105k pm
PI’s can share in cash raises
New strategy for womens health and new oncology
Streamlining the legacy assets and attempting to commercialise
New lab to fasttrack new IP, which l might add is hinted in the last RNS as revenue generating
Collaborations with Global Uni Medical Teams
The list goes on!
So….pretty good l say and don’t focus on a few weeks where investors like me and you have lost a few pennies - look at the bigger picture!
GLA
Also by not agreeing to the resolutions IMHO is simply shooting yourself in the foot or to use another metaphor, cutting off your nose to spite your face.
I’m sure we will have a train load of news soon.
The success of the THX fund raise is down to THX, not Suzy. VAL have probably done months of DD and work behind the scenes which we all don’t know about.
Why give new IP THX if it doesn’t stack up? These are clever people and Kevin Cox has much experience in corporate deals as do Cenkos and their Nomad.
The delay is understandable considering the current climate and hey!
Is it the end of June yet?
Great reply from Suzy!
The question is…. why extend if it its a non-starter with THX? Doesn’t make sense.
Reading between the lines, l think they are close IMHO to get it over the line and close the fund raise.
Its been a tough fund raising environment with businesses not operating properly with covid easing Feb 2022, then the Ukraine situation to date and rising interest rates, food and energy costs so a lot of investment houses in H1 2022 put the breaks on new investments until things were clearer.
Frustrating l know but l think THX are very genuine and why would VAL introduce more IP to them if things weren’t progressing plus setting out the terms of the 201 trial?
Think we should hopefully see some blue days soon.
GLA
Geoffs, difference here is that the annual report RNS said it was already revenue generating! ??
Yes Ice, think we should hopefully get a bit of a bounce now - bad out, good in!
A couple of points there South, if the money from THX is forthcoming then a little more is needed in the kitty to tie things over.
No need to be heavily discounted, albeit a discount required to make it attractive but long gone are the toxic convertible loan notes of the previous board, plus Suzy as per last fund raise allowed PI’s to invest so if you invest, your personal dilution is mitigated.
Another point apart from working capital….. if a fund raise is used to enhance the business then the added value or asset is actually a positive and not a negative.
People confuse a placing with a fire-sale for businesses that are struggling. VAL has a portfolio of valuable assets, a superb board that refocussed its strategy and stripped out dead IP (101), plus completely slashed the costs and cash burn moving the share price from less than 0.5p to where we are today.
People get short sighted and lose track of where we were a few years ago to where we are now.
Well l think Suzy’s reply is spot on and l think we should all be less critical and more accommodating for what is a tough fund raising environment after Covid, then Ukraine and rising interest rates, energy and food prices - investors are naturally being more cautious than the norm.
IMHO l think it is business as usual for VAL, albeit slightly delayed with THX again but I’d rather be patient and wait rather than starting the whole process again which would be ludicrous.
Lots of other news IMHO to arrive - BC update, BC201 and the lab which l think will be the crunch turning point of revenue generation and fast-tracking the new strategy, whilst they continue to license out / sale the legacy assets.
GLA and l expect calm after soothing nerves over the weekend having time to reflect.
Well said Ironmighty.
My goodness, PMT overload here!
Patience required as if it was a no go then VAL would say so!
Enjoy the weather and relax guys, its still on and good things sometimes take time and run over schedule.
All l can say is read the www.
Couple of points there South….
1. Lab a massive addition!!!!! That is patamount if you see the last RNS. Sounds like an acquisition of an existing CRO so already revenue generating so will be VAL’s first ever income stream!
2. Cost and revenue of the lab - tbc, but Suzy and team and savvy enough to make sure its a solid purchase in the interests of shareholders.
3. THX is external and a bonus or vicerversa!
CB, maybe more than one thing l guess, in addition to THX?